Venture Center (Official Account)的动态

?? Exciting News from Bharatiya Media! ?? We’re thrilled to share our latest editorial on Global Bio-India 2024, a landmark event that promises to shape the future of the biotechnology industry in India and beyond! In our in-depth coverage, we delve into: ?? Innovative Breakthroughs: Discover the cutting-edge advancements and groundbreaking research set to be showcased at the event. ?? Global Impact: Understand how Global Bio-India 2024 is poised to influence the global biotech landscape and foster international collaborations. ?? Opportunities for Growth: Learn about the opportunities for startups, SMEs, and established businesses to engage, network, and thrive in the evolving biotech ecosystem. ?? Keynote Insights: Gain valuable perspectives from industry leaders, thought pioneers, and visionaries who will be sharing their insights and experiences. This editorial provides a comprehensive overview of what to expect and how this prestigious event will serve as a catalyst for innovation and growth in the biotech sector. ?? Read the full editorial here: https://lnkd.in/gXqkq8RR Join the conversation and stay updated with the latest developments on Startups, SMEs and Businesses by following Bharatiya Media. Let’s explore the future of Entrepreneurship together! #GlobalBioIndia2024 #Biotech #Innovation #Startups #SMEs #BharatiyaMedia #Editorial #BusinessNews

In a recent interaction with Express Pharma, Dr. Samir Vyas, Country General Manager, India, shed light on the significant role of startups, incubators, and investment trends in the biopharma industry. The article also underscores Agilent’s collaborations and recent technological advancements that are aiding not just startups but also large biopharma organizations. Read more about this article here - https://lnkd.in/dHgu-DWG #AgilentIndia #Biopharma #Innovation Ankush Sharma Chirag Khambhati Lalit Hansoge Aishwarya Chandran Manthan Satiya Ankur Srivastava

?? Cabinet Approves Bio-Ride Scheme to Boost Biotech Startups. In a significant move to foster innovation, the Indian cabinet has approved the Bio-Ride scheme aimed at promoting biotechnology startups across the country. ?? Strategic Initiative: - The Bio-Ride scheme will provide financial support and resources to emerging biotech firms, encouraging research and development in the sector. - This initiative underscores the government's commitment to bolstering the biotech ecosystem and driving economic growth. ?? Support for Startups: - The scheme will facilitate access to funding, mentorship, and infrastructure for biotech startups, helping them scale their operations. - By enhancing collaboration between academia and industry, Bio-Ride aims to accelerate the commercialization of biotech innovations. ?? Market Potential: - India’s biotechnology sector is poised for significant growth, with increasing demand for innovative solutions in healthcare, agriculture, and environmental sustainability. - The Bio-Ride scheme aims to position India as a global leader in biotechnology, leveraging its vast talent pool and research capabilities. ?? Future Vision: - The government envisions a thriving biotech ecosystem that not only drives economic growth but also addresses critical challenges in healthcare and sustainability. - By supporting startups, the Bio-Ride scheme aims to create job opportunities and promote entrepreneurship in the biotech domain. The cabinet's approval of the Bio-Ride scheme marks a pivotal step towards enhancing India's biotech landscape, paving the way for innovation and sustainable development in the sector. #BioRide #BiotechStartups #Innovation #GovernmentInitiative #Entrepreneurship #microshots #SustainableDevelopment

CIIC team interacted with Dr.M.Manivannan, Professor in charge of XTIC, IIT Madras and witnessed the product demos of their startup’s. CIIC has signed an MoU with XTIC (Experiential Technology Innovation Centre) https://xtic.org/ at the IIT Madras recently. This partnership aims to transform the XR landscape by driving innovation in Augumented Reality, Virtual Reality, and Mixed Reality and adding haptics feedback. This collaboration of CIIC and XTIC fosters growth and supports cutting-edge CIIC startups through mentoring and market-connect support to their product development. Manivannan Muniyandi | Indian Institute of Technology, Madras | BSA Crescent Institute of Science and Technology | AIC - CIIC | All India Council for Technical Education (AICTE) | MoE's Innovation Cell? | Department for Promotion of Industry and Internal Trade | Department of Science & Technology, Government of India |Department of Biotechnology |Ministry of Micro, Small and Medium Enterprises, Government of India |Entrepreneurship Development and Innovation Institute | DBT BIRAC | iDEX - DIO |MeitY Startup Hub| Atal Innovation Mission Official |StartupTN | Tamil Nadu Technology Hub (iTNT) | Guidance Tamil Nadu | TN - RISE Women Startup Council | Tamil Nadu Infrastructure Fund Management Corporation Ltd. (TNIFMC)| TICEL BIO PARK | Abdul Qadir Abdul Rahman Buhari | Parvez Alam M | Nisha Mukund Ph.D| NATARAJAN T.R | Santhosh S | kiran chandran |

Indian biotech startups made a significant mark at Global Bio India 2024, unveiling 11 pioneering products with the potential to transform India’s biotech ecosystem. The developments reflect the immense potential of the sector in driving transformative solutions across healthcare and technology. BioAngels is proud to represent and support this vibrant community driving advancements in healthcare and technology. Read more: https://lnkd.in/dfK4-Q-W #GlobalBioIndia2024 #BiotechInnovation #BioAngels #StartupEcosystem

?? ?????????????????????? ?????? ?????????? ???????????? ?????? ?????????????????????????????????? (??????) ???????????????????? ?????????????????? 2025 This exciting initiative provides an exceptional platform for start-ups and individuals with innovative ideas in the Agri, Food, Healthcare, and Allied sectors to develop, scale, and expand their ventures. ???????????????????????? ????????: https://lnkd.in/gQttQRwf ???????????????????????? ????????????????: 14 ?????? 2025 Who Can Apply? 1. Individuals or early-stage start-ups with innovative ideas 2. Proof of Concept (PoC) 3. Prototype 4. Minimum Viable Product (MVP) 5. Solutions in the Agri, Food, Healthcare, and Allied sectors. What the RCN Incubation Programme Offers: ? Access to advanced laboratories, Minor and Major Equipment, workspaces, and expert guidance for R&D. ?Assistance in creating business strategies, financial planning, and navigating regulatory requirements. ?Access to grants, seed funding, and connections with investors. ?Opportunities to partner with researchers, industry leaders, and healthcare organizations. ?Support in product testing, consultancy, clinical trials, and understanding market trends. ?Mentorship, training, and strategic advice for scaling operations and building a brand. Programme Details: ????????????????????? ????????????: 12 ????????????? ????????????????????? ??????: ???????????? ???????? ?4,000/??????????? ??????????????? ???????????????????? ??????: ???????????? ???????? ?2,000/?????????? Seize this opportunity to collaborate with RCN, AIC RAISE, and take your start-up to the next level with the support of the RCN Incubation Programme. For Further info: [email protected], +91 8870697986, https://lnkd.in/gfa8TEkT Dr. S. P. Suriyaraj | Dr Nagaraj Balakrishnan | pradeepraj m s | Dinu Anand R | Nagadharshini R | Navaneeth K | Karthiga Subramanian | Varsha Marisamy | Raseena Parveen M | Biotechnology Industry Research Assistance Council (BIRAC) | Anusandhan National Research Foundation (ANRF) | Indian Council of Social Sciences Research (ICSSR) | StartupTN | Startup India | Defence Research and Development Organisation (DRDO) | DBT BIRAC | Ministry of Science and Technology | NITI Aayog | Rathinam Group | AIC RAISE | MyGov India |

?????? ???????? ???????? ???????? ???????????? ?????? ?????????????? ????????????????? ?????? ???????? ???????? ???? ?????? ????????????? The struggle for early-stage MedTech startups to secure seed funding is real—and I've seen it firsthand. Just last week, I read an insightful article in Nature Biotechnology (link in comments) that highlighted the current state of financing in Biotech. The findings are strikingly relevant to MedTech as well. Here’s the summary: ? ?????????????? ?????????????? ???? ??????????????—but primarily into Series A, B, and C rounds for more mature startups with experienced leadership and proven technologies in clinical stages (later-stage development). ? ???????? ??????????????, ??????????????, ???? ????????????. Investors are hesitant to back startups in the pre-clinical stages, where core technologies still need significant de-risking (early-stage development). This has created a polarized environment of "haves" and "have-nots." ?????? ?????? ???????????????????????? ????????????????? Higher interest rates and an abundance of attractive, lower-risk clinical-stage companies emerging from the pandemic's peak years mean investors can choose less risky opportunities at appealing valuations. ????, ???????? ???????? ??????????-?????????? ???????????????????? ?????????????? ???????? ??????????????? It’s hard to say. But one thing is clear: For the Biotech and MedTech sectors to keep growing, we’ll need fresh, innovative technologies. And that can only happen if we start fueling early-stage startups again. Let’s hope that day comes sooner rather than later. #Medtech #Biotech #MedicalDevices #Innovation

Happy to share that our incubated startup,?Promecens Entosystems Private Limited?has filed a provisional patent for a method of extracting high-grade melanin from ???????????????? ???????????????? larvae. The high-purity melanin developed by them acts as a sustainable and versatile alternative that addresses critical needs across diverse industries such as cosmetics, pharmaceuticals, electronics, and renewable energy. Abhinav Chauhan | Aman Dahiya | Himani jain BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD) | Department of Biotechnology | Startup India | Biotechnology Industry Research Assistance Council (BIRAC) M Kavita R. | Dibyadarshi Ranasingh #CDFDTechnologyIncubator #sustainability #patents #entrepreneurship #incubation #startups #biotech #startupmilestone #innovation

This year's biotech startups are at the cutting edge of innovation, tackling global challenges with groundbreaking solutions ?? ??Take a look at which companies you need to watch this year #BiotechJobs #PharmaRecruitment #QualityAssurance #LifeSciences #HealthcareRecruitment #BiotechCareers

?? MSMF-TBI Quarterly Newsletter | Q4 2024 ?? As we wrap up an incredible year at MSMF-TBI, we’re thrilled to present our Q4 2024 Newsletter, a glimpse into the dynamic initiatives, milestones, and achievements from the last quarter. ?? What’s Inside? ? Game-changing partnerships and collaborations ? Highlights from our ecosystem-building activities ? Success stories of our incubated startups ? Insights into upcoming events and opportunities This edition reflects our commitment to driving innovation in healthcare and medtech, fostering growth, and empowering startups to make a real-world impact. Here’s to innovation, collaboration, and a transformative 2025! ?? Kiran Mazumdar Shaw | Dr.Paul C. Salins | Kiran Vuppala | SAMARTH SHETTY | Salai Jeyaseelan Annamalai | Dr Harshitha Balasubramanian . | kartheek s.a | Karuppasamy M Narayana Health | Biocon | DBT BIRAC | Biotechnology Industry Research Assistance Council (BIRAC) | Startup India | Mazumdar Shaw Medical Foundation #MSMFTBI #HealthcareInnovation #StartupEcosystem #MedTech #Entrepreneurship #Innovation #Newsletter